HLTH 2022: Neurotrack’s CEO Stresses Need For Three-Minute Digital Test To Detect Cognitive Decline Early
Executive Summary
Neurotrack hopes to bring its three-minute digital cognitive assessment tool into primary care offices as part of the Medicare Annual Wellness visit.
You may also be interested in...
Neurotrack Rethinks ‘Cognitive Health Program’ Website Following Ad Claims Challenge
Neurotrack Technologies revises website “to ensure that its communications better align with its evidence-backed offerings” following a National Advertising Division review of an advertising challenge by Posit Science.
Neurotrack Rethinks ‘Cognitive Health Program’ Website Following Ad Claims Challenge
Neurotrack Technologies revises website “to ensure that its communications better align with its evidence-backed offerings” following a National Advertising Division review of an advertising challenge by Posit Science.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.